155 related articles for article (PubMed ID: 17804226)
1. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies.
Richardson TI; Dodge JA; Wang Y; Durbin JD; Krishnan V; Norman BH
Bioorg Med Chem Lett; 2007 Oct; 17(20):5563-6. PubMed ID: 17804226
[TBL] [Abstract][Full Text] [Related]
2. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
Richardson TI; Dodge JA; Durst GL; Pfeifer LA; Shah J; Wang Y; Durbin JD; Krishnan V; Norman BH
Bioorg Med Chem Lett; 2007 Sep; 17(17):4824-8. PubMed ID: 17614275
[TBL] [Abstract][Full Text] [Related]
3. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring.
Norman BH; Richardson TI; Dodge JA; Pfeifer LA; Durst GL; Wang Y; Durbin JD; Krishnan V; Dinn SR; Liu S; Reilly JE; Ryter KT
Bioorg Med Chem Lett; 2007 Sep; 17(18):5082-5. PubMed ID: 17662603
[TBL] [Abstract][Full Text] [Related]
4. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
[TBL] [Abstract][Full Text] [Related]
5. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists.
Sun W; Cama LD; Birzin ET; Warrier S; Locco L; Mosley R; Hammond ML; Rohrer SP
Bioorg Med Chem Lett; 2006 Mar; 16(6):1468-72. PubMed ID: 16412638
[TBL] [Abstract][Full Text] [Related]
6. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
[TBL] [Abstract][Full Text] [Related]
7. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of estrogen receptor-beta selective ligands.
Manas ES; Unwalla RJ; Xu ZB; Malamas MS; Miller CP; Harris HA; Hsiao C; Akopian T; Hum WT; Malakian K; Wolfrom S; Bapat A; Bhat RA; Stahl ML; Somers WS; Alvarez JC
J Am Chem Soc; 2004 Nov; 126(46):15106-19. PubMed ID: 15548008
[TBL] [Abstract][Full Text] [Related]
10. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
McDevitt RE; Malamas MS; Manas ES; Unwalla RJ; Xu ZB; Miller CP; Harris HA
Bioorg Med Chem Lett; 2005 Jun; 15(12):3137-42. PubMed ID: 15876535
[TBL] [Abstract][Full Text] [Related]
12. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
Mewshaw RE; Bowen SM; Harris HA; Xu ZB; Manas ES; Cohn ST
Bioorg Med Chem Lett; 2007 Feb; 17(4):902-6. PubMed ID: 17188490
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands.
Chesworth R; Wessel MD; Heyden L; Mangano FM; Zawistoski M; Gegnas L; Galluzzo D; Lefker B; Cameron KO; Tickner J; Lu B; Castleberry TA; Petersen DN; Brault A; Perry P; Ng O; Owen TA; Pan L; Ke HZ; Brown TA; Thompson DD; DaSilva-Jardine P
Bioorg Med Chem Lett; 2005 Dec; 15(24):5562-6. PubMed ID: 16219463
[TBL] [Abstract][Full Text] [Related]
14. Design of a highly selective and potent class of non-planar estrogen receptor β agonists.
Sundén H; Ma JN; Hansen LK; Gustavsson AL; Burstein ES; Olsson R
ChemMedChem; 2013 Aug; 8(8):1283-94. PubMed ID: 23784708
[TBL] [Abstract][Full Text] [Related]
15. ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
Yang C; Edsall R; Harris HA; Zhang X; Manas ES; Mewshaw RE
Bioorg Med Chem; 2004 May; 12(10):2553-70. PubMed ID: 15110838
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
17. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists.
Parker DL; Meng D; Ratcliffe RW; Wilkening RR; Sperbeck DM; Greenlee ML; Colwell LF; Lambert S; Birzin ET; Frisch K; Rohrer SP; Nilsson S; Thorsell AG; Hammond ML
Bioorg Med Chem Lett; 2006 Sep; 16(17):4652-6. PubMed ID: 16777408
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
19. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
De Angelis M; Stossi F; Waibel M; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2005 Dec; 13(23):6529-42. PubMed ID: 16099659
[TBL] [Abstract][Full Text] [Related]
20. Descriptor analysis of estrogen receptor β-selective ligands using 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy 6H-benzo[c]chromen-6-one scaffolds.
Balaji ; Muthiah R; Sabarinath ; Ramamurthy ; Chandrasekharan
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):831-42. PubMed ID: 21438712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
